Production of complex viral glycoproteins in plants as vaccine immunogens

Plant Biotechnology Journal

Volumn 16, Issue 9, 2018, Pages 1531-1545

  Margolin, Emmanuel ^a,b   Chapman, Ros ^a   Williamson, Anna Lise ^a   Rybicki, Edward P ^a,b   Meyers, Ann E ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

biopharming; chaperone; glycoprotein; vaccine

Indexed keywords

EID: 85050455412     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12963     Document Type: Review

References (181)

1. Andrabi, R., Voss, J.E., Liang, C.H., Briney, B., McCoy, L.E., Wu, C.Y., Wong, C.H. et al. (2015) Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design. Immunity, 43, 959–973.
2. Andrabi, R., Su, C.Y., Liang, C.H., Shivatare, S.S., Briney, B., Voss, J.E., Nawazi, S.K. et al. (2017) Glycans function as anchors for antibodies and help drive HIV broadly neutralizing antibody development. Immunity, 47, 524–537. e523.
3. Ashraf, S., Singh, P.K., Yadav, D.K., Shahnawaz, M., Mishra, S., Sawant, S.V. and Tuli, R. (2005) High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J. Biotechnol. 119, 1–14.
4. Bachmann, M.F. and Jennings, G.T. (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787–796.
5. Balla-Jhagjhoorsingh, S.S., Corti, D., Heyndrickx, L., Willems, E., Vereecken, K., Davis, D. and Vanham, G. (2013) The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody. PLoS ONE, 8, e68863.
6. Bardor, M., Faveeuw, C., Fitchette, A.C., Gilbert, D., Galas, L., Trottein, F., Faye, L. et al. (2003) Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. Glycobiology, 13, 427–434.
7. Beasley, D.W. and Barrett, A.D. (2002) Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 76, 13097–13100.
8. Berinstein, A., Vazquez-Rovere, C., Asurmendi, S., Gomez, E., Zanetti, F., Zabal, O., Tozzini, A. et al. (2005) Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine, 23, 5583–5589.
9. Binley, J.M., Sanders, R.W., Clas, B., Schuelke, N., Master, A., Guo, Y., Kajumo, F. et al. (2000) A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 74, 627–643.
10. Binley, J.M., Sanders, R.W., Master, A., Cayanan, C.S., Wiley, C.L., Schiffner, L., Travis, B. et al. (2002) Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 76, 2606–2616.
11. Blattner, C., Lee, J.H., Sliepen, K., Derking, R., Falkowska, E., de la Pena, A.T., Cupo, A. et al. (2014) Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity, 40, 669–680.
12. de Boer, S.M., Kortekaas, J., Antonis, A.F., Kant, J., van Oploo, J.L., Rottier, P.J., Moormann, R.J. et al. (2010) Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. Vaccine, 28, 2330–2339.
13. Bonomelli, C., Doores, K.J., Dunlop, D.C., Thaney, V., Dwek, R.A., Burton, D.R., Crispin, M. et al. (2011) The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. PLoS ONE, 6, e23521.
14. Bosch, D. and Schots, A. (2010) Plant glycans: friend or foe in vaccine development? Expert. Rev. Vaccines, 9, 835–842.
15. Braakman, I. and Hebert, D.N. (2013) Protein folding in the endoplasmic reticulum. Cold Spring Harb. Perspect. Biol. 5, a013201.
16. Bullough, P.A., Hughson, F.M., Skehel, J.J. and Wiley, D.C. (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature, 371, 37–43.
17. Cao, L., Diedrich, J.K., Kulp, D.W., Pauthner, M., He, L., Park, S.R., Sok, D. et al. (2017) Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nat. Commun. 8, 14954.
18. Cardona-Ospina, J.A., Sepulveda-Arias, J.C., Mancilla, L. and Gutierrez-Lopez, L.G. (2016) Plant expression systems, a budding way to confront chikungunya and Zika in developing countries? F1000Res, 5, 2121.
19. Castilho, A. and Steinkellner, H. (2012) Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnol. J. 7, 1088–1098.
20. Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., Kunert, R. et al. (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J. Biol. Chem. 285, 15923–15930.
21. Castilho, A., Neumann, L., Gattinger, P., Strasser, R., Vorauer-Uhl, K., Sterovsky, T., Altmann, F. et al. (2013) Generation of biologically active multi-sialylated recombinant human EPOFc in plants. PLoS ONE, 8, e54836.
22. Castilho, A., Beihammer, G., Pfeiffer, C., Goritzer, K., Montero-Morales, L., Vavra, U., Moresch, D. et al. (2018) An oligosacchyaryl transferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana. Plant Biotechnol. J. https://doi.org/10.1111/pbi.12906, In press.
23. Chen, B.J., Leser, G.P., Morita, E. and Lamb, R.A. (2007) Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 81, 7111–7123.
24. Chen, T.-H., Hu, C.-C., Liao, J.-T., Lee, Y.-L., Huang, Y.-W., Lin, N.-S., Lin, Y.-L. et al. (2017) Production of Japanese encephalitis virus antigens in plants using bamboo mosaic virus-based vector. Front. Microbiol. 8, 788.
25. Chichester, J.A., Jones, R.M., Green, B.J., Stow, M., Miao, F., Moonsammy, G., Streatfield, S.J. et al. (2012) Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults. Viruses, 4, 3227–3244.
26. Crill, W.D. and Roehrig, J.T. (2001) Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769–7773.
27. Crispin, M., Ward, A.B. and Wilson, I.A. (2018) Structure and immune recognition of the HIV Glycan shield. Annu. Rev. Biophys. 47, 499–523.
28. Crooks, E.T., Tong, T., Osawa, K. and Binley, J.M. (2011) Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected. J. Virol. 85, 5825–5839.
29. Cummings, J.F., Guerrero, M.L., Moon, J.E., Waterman, P., Nielsen, R.K., Jefferson, S., Gross, F.L. et al. (2014) Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine, 32, 2251–2259.
30. Daniels, R., Kurowski, B., Johnson, A.E. and Hebert, D.N. (2003) N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell. 11, 79–90.
31. D'Aoust, M.A., Lavoie, P.O., Couture, M.M., Trepanier, S., Guay, J.M., Dargis, M., Mongrand, S. et al. (2008) Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J. 6, 930–940.
32. D'Aoust, M.A., Couture, M.M., Charland, N., Trepanier, S., Landry, N., Ors, F. and Vezina, L.P. (2010) The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J. 8, 607–619.
33. Decroly, E., Vandenbranden, M., Ruysschaert, J.M., Cogniaux, J., Jacob, G.S., Howard, S.C., Marshall, G. et al. (1994) The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J. Biol. Chem. 269, 12240–12247.
34. Decroly, E., Wouters, S., Di Bello, C., Lazure, C., Ruysschaert, J.M. and Seidah, N.G. (1996) Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines. J. Biol. Chem. 271, 30442–30450.
35. Doores, K.J., Bonomelli, C., Harvey, D.J., Vasiljevic, S., Dwek, R.A., Burton, D.R., Crispin, M. et al. (2010) Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl Acad. Sci. U. S. A. 107, 13800–13805.
36. Dugan, V. (2017) Update: Influenza Activity — United States, October 1–November 25, 2017. In: Morbidity and Mortality Weekly Report (MMWR). Centers for Disease Control and Prevention.
37. Edgue, G., Twyman, R.M., Beiss, V., Fischer, R. and Sack, M. (2017) Antibodies from plants for bionanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 9, c1462.
38. Falkowska, E., Le, K.M., Ramos, A., Doores, K.J., Lee, J.H., Blattner, C., Ramirez, A. et al. (2014) Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity, 40, 657–668.
39. Faye, L., Boulaflous, A., Benchabane, M., Gomord, V. and Michaud, D. (2005) Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine, 23, 1770–1778.
40. Fischer, R., Schumann, D., Zimmermann, S., Drossard, J., Sack, M. and Schillberg, S. (1999) Expression and characterization of bispecific single-chain Fv fragments produced in transgenic plants. Eur. J. Biochem. 262, 810–816.
41. Frickel, E.M., Frei, P., Bouvier, M., Stafford, W.F., Helenius, A., Glockshuber, R. and Ellgaard, L. (2004) ERp57 is a multifunctional thiol-disulfide oxidoreductase. J. Biol. Chem. 279, 18277–18287.
42. Galloway, S.E., Reed, M.L., Russell, C.J. and Steinhauer, D.A. (2013) Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog. 9, e1003151.
43. Georgiev, I.S., Joyce, M.G., Yang, Y., Sastry, M., Zhang, B., Baxa, U., Chen, R.E. et al. (2015) Single-chain soluble BG505.SOSIP gp140 trimers as structural and antigenic mimics of mature closed HIV-1 Env. J. Virol. 89, 5318–5329.
44. Ghiasi, S.M., Salmanian, A.H., Chinikar, S. and Zakeri, S. (2011) Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus. Clin. Vaccine Immunol. 18, 2031–2037.
45. Go, E.P., Hua, D. and Desaire, H. (2014) Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation. J. Proteome Res. 13, 4012–4027.
46. Gomez, E., Zoth, S.C., Asurmendi, S., Rovere, C.V. and Berinstein, A. (2009) Expression of Hemagglutinin-Neuraminidase glycoprotein of Newcastle Disease Virus in agroinfiltrated Nicotiana benthamiana plants. J. Biotechnol. 144, 337–340.
47. Gorman, J., Soto, C., Yang, M.M., Davenport, T.M., Guttman, M., Bailer, R.T., Chambers, M. et al. (2016) Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design. Nat. Struct. Mol. Biol. 23, 81–90.
48. Goulet, C., Khalf, M., Sainsbury, F., D'Aoust, M.A. and Michaud, D. (2012) A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast. Plant Biotechnol. J. 10, 83–94.
49. Gu, M., Rappaport, J. and Leppla, S.H. (1995) Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett. 365, 95–97.
50. Guerrero-Andrade, O., Loza-Rubio, E., Olivera-Flores, T., Fehervari-Bone, T. and Gomez-Lim, M.A. (2006) Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic Res. 15, 455–463.
51. Hajj Hussein, I., Chams, N., Chams, S., El Sayegh, S., Badran, R., Raad, M., Gerges-Geagea, A. et al. (2015) Vaccines through centuries: major cornerstones of global health. Front. Public Health, 3, 269.
52. Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.D. and Garten, W. (1992) Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature, 360, 358–361.
53. He, J., Peng, L., Lai, H., Hurtado, J., Stahnke, J. and Chen, Q. (2014) A plant-produced antigen elicits potent immune responses against West Nile virus in mice. Biomed. Res. Int. 2014, 952865.
54. Hefferon, K. (2013) Plant-derived pharmaceuticals for the developing world. Biotechnol. J. 8, 1193–1202.
55. Hegde, R.S. and Bernstein, H.D. (2006) The surprising complexity of signal sequences. Trends Biochem. Sci. 31, 563–571.
56. Herve, P.L., Lorin, V., Jouvion, G., Da Costa, B. and Escriou, N. (2015) Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity. Virology, 486, 134–145.
57. Hiller, M.M., Finger, A., Schweiger, M. and Wolf, D.H. (1996) ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science, 273, 1725–1728.
58. Horn, M.E., Pappu, K.M., Bailey, M.R., Clough, R.C., Barker, M., Jilka, J.M., Howard, J.A. et al. (2003) Advantageous features of plant-based systems for the development of HIV vaccines. J. Drug Target. 11, 539–545.
59. Howell, S.H. (2013) Endoplasmic reticulum stress responses in plants. Annu. Rev. Plant Biol. 64, 477–499.
60. Hsu, T.A. and Betenbaugh, M.J. (1997) Coexpression of molecular chaperone BiP improves immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells. Biotechnol. Prog. 13, 96–104.
61. Iuliano, A.D., Roguski, K.M., Chang, H.H., Muscatello, D.J., Palekar, R., Tempia, S., Cohen, C. et al. (2017) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet, 391, 1285–1300.
62. Jardine, J., Julien, J.P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D. et al. (2013) Rational HIV immunogen design to target specific germline B cell receptors. Science, 340, 711–716.
63. Jensen, T.J., Loo, M.A., Pind, S., Williams, D.B., Goldberg, A.L. and Riordan, J.R. (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell, 83, 129–135.
64. Jin, C., Altmann, F., Strasser, R., Mach, L., Schahs, M., Kunert, R., Rademacher, T. et al. (2008) A plant-derived human monoclonal antibody induces an anticarbohydrate immune response in rabbits. Glycobiology, 18, 235–241.
65. Job, E.R., Deng, Y.M., Barfod, K.K., Tate, M.D., Caldwell, N., Reddiex, S., Maurer-Stroh, S. et al. (2013) Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses. J. Immunol. 190, 2169–2177.
66. Joyce, M.G., Zhang, B., Ou, L., Chen, M., Chuang, G.Y., Druz, A., Kong, W.P. et al. (2016) Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV. Nat. Struct. Mol. Biol. 23, 811–820.
67. Julien, J.P., Cupo, A., Sok, D., Stanfield, R.L., Lyumkis, D., Deller, M.C., Klasse, P.J. et al. (2013) Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science, 342, 1477–1483.
68. Jutras, P.V., D'Aoust, M.A., Couture, M.M., Vezina, L.P., Goulet, M.C., Michaud, D. and Sainsbury, F. (2015) Modulating secretory pathway pH by proton channel co-expression can increase recombinant protein stability in plants. Biotechnol. J. 10, 1478–1486.
69. Kaaijk, P. and Luytjes, W. (2017) Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination. Hum. Vaccin. Immunother. 14, 337–344.
70. Kalbina, I., Lagerqvist, N., Moiane, B., Ahlm, C., Andersson, S., Strid, A. and Falk, K.I. (2016) Arabidopsis thaliana plants expressing Rift Valley fever virus antigens: mice exhibit systemic immune responses as the result of oral administration of the transgenic plants. Protein Expr. Purif. 127, 61–67.
71. Kallolimath, S. and Steinkellner, H. (2015) Glycosylation of plant produced human antibodies. Hum. Antibodies, 23, 45–48.
72. Kallolimath, S., Castilho, A., Strasser, R., Grunwald-Gruber, C., Altmann, F., Strubl, S., Galuska, C.E. et al. (2016) Engineering of complex protein sialylation in plants. Proc. Natl Acad. Sci. U. S. A. 113, 9498–9503.
73. Kanagaraj, A.P., Verma, D. and Daniell, H. (2011) Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol. Biol. 76, 323–333.
74. Karczewski, J. and Ysibov, V. (2016) Plant-based technologies to enable rapid response to Ebola outbreak.
75. Karlsson Hedestam, G.B., Fouchier, R.A., Phogat, S., Burton, D.R., Sodroski, J. and Wyatt, R.T. (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat. Rev. Microbiol. 6, 143–155.
76. Kessans, S.A., Linhart, M.D., Matoba, N. and Mor, T. (2013) Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana. Plant Biotechnol. J. 11, 681–690.
77. Kim, T.G., Kim, M.Y. and Yang, M.S. (2010) Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants. Protein Expr. Purif. 74, 236–241.
78. Kim, M.Y., Yang, M.S. and Kim, T.G. (2012) Expression of a consensus dengue virus envelope protein domain III in transgenic callus of rice. Plant Cell. Tiss. Org. 109, 509–515.
79. Kong, L., Sheppard, N.C., Stewart-Jones, G.B., Robson, C.L., Chen, H., Xu, X., Krashias, G. et al. (2010) Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. J. Mol. Biol. 403, 131–147.
80. Kong, L., Lee, J.H., Doores, K.J., Murin, C.D., Julien, J.P., McBride, R., Liu, Y. et al. (2013) Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat. Struct. Mol. Biol. 20, 796–803.
81. Land, A., Zonneveld, D. and Braakman, I. (2003) Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J. 17, 1058–1067.
82. Landry, N., Ward, B.J., Trepanier, S., Montomoli, E., Dargis, M., Lapini, G. and Vezina, L.P. (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE, 5, e15559.
83. Landry, N., Pillet, S., Favre, D., Poulin, J.F., Trepanier, S., Yassine-Diab, B. and Ward, B.J. (2014) Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens. Clin. Immunol. 154, 164–177.
84. Lannoo, N. and Van Damme, E.J. (2015) Review/N-glycans: the making of a varied toolbox. Plant Sci. 239, 67–83.
85. Lasky, L.A., Groopman, J.E., Fennie, C.W., Benz, P.M., Capon, D.J., Dowbenko, D.J., Nakamura, G.R. et al. (1986) Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science, 233, 209–212.
86. Le Mauff, F., Mercier, G., Chan, P., Burel, C., Vaudry, D., Bardor, M., Vezina, L.P. et al. (2015) Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants. Plant Biotechnol. J. 13, 717–725.
87. Leonard, C.K., Spellman, M.W., Riddle, L., Harris, R.J., Thomas, J.N. and Gregory, T.J. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10373–10382.
88. Li, Y., Bergeron, J.J., Luo, L., Ou, W.J., Thomas, D.Y. and Kang, C.Y. (1996) Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. Proc. Natl Acad. Sci. U. S. A. 93, 9606–9611.
89. Li, Y., Luo, L., Thomas, D.Y. and Kang, C.Y. (2000) The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Virology, 272, 417–428.
90. Li, H.Y., Ramalingam, S. and Chye, M.L. (2006) Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines. Exp. Biol. Med. (Maywood) 231, 1346–1352.
91. Lippincott-Schwartz, J., Bonifacino, J.S., Yuan, L.C. and Klausner, R.D. (1988) Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins. Cell, 54, 209–220.
92. Liu, J.X. and Howell, S.H. (2010) Endoplasmic reticulum protein quality control and its relationship to environmental stress responses in plants. Plant Cell. 22, 2930–2942.
93. Loza-Rubio, E., Rojas, E., Gomez, L., Olivera, M.T. and Gomez-Lim, M.A. (2008) Development of an edible rabies vaccine in maize using the Vnukovo strain. Dev. Biol. (Basel) 131, 477–482.
94. Loza-Rubio, E., Rojas-Anaya, E., Lopez, J., Olivera-Flores, M.T., Gomez-Lim, M. and Tapia-Perez, G. (2012) Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine, 30, 5551–5556.
95. Lyumkis, D., Julien, J.P., de Val, N., Cupo, A., Potter, C.S., Klasse, P.J., Burton, D.R. et al. (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science, 342, 1484–1490.
96. Ma, J.K., Christou, P., Chikwamba, R., Haydon, H., Paul, M., Ferrer, M.P., Ramalingam, S. et al. (2013) Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies. Plant Biotechnol. J. 11, 1029–1033.
97. Major, D., Chichester, J.A., Pathirana, R.D., Guilfoyle, K., Shoji, Y., Guzman, C.A., Yusibov, V. et al. (2015) Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. Hum. Vacc. Immunother. 11, 1235–1243.
98. Manini, I., Trombetta, C., Lazzeri, G., Pozzi, T., Rossi, S. and Montomoli, E. (2017) Egg-Independent Influenza Vaccines and Vaccine Candidates. Vaccines, 5, 18.
99. Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P. and Bachmann, M.F. (2008) Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404–1413.
100. Margolin, E., Chapman, R., Meyers, A.E., van Diepen, M., Ximba, P., Hermanus, T., et al. (submitted for publication) Production and immunogenicity of soluble plant-produced HIV-1 subtype C Envelope gp140 immunogens.
101. Martinez, C.A., Topal, E., Giulietti, A.M., Talou, J.R. and Mason, H. (2010) Exploring different strategies to express Dengue virus envelope protein in a plant system. Biotechnol. Lett. 32, 867–875.
102. Mbewana, S. (2017) The development of Rift Valley fever virus candidate vaccines and reagents produced in Nicotiana benthamiana. Molecular & Cell Biology. University of Cape Town. http://open.UCT.ac.za/handle/11427/25446.
103. McGarvey, P.B., Hammond, J., Dienelt, M.M., Hooper, D.C., Fu, Z.F., Dietzschold, B., Koprowski, H. et al. (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology (N Y) 13, 1484–1487.
104. McGuire, A.T., Hoot, S., Dreyer, A.M., Lippy, A., Stuart, A., Cohen, K.W., Jardine, J. et al. (2013) Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J. Exp. Med. 210, 655–663.
105. Medlock, J., Pandey, A., Parpia, A.S., Tang, A., Skrip, L.A. and Galvani, A.P. (2017) Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proc. Natl Acad. Sci. U. S. A. 114, 4017–4022.
106. Mett, V., Musiychuk, K., Bi, H., Farrance, C.E., Horsey, A., Ugulava, N., Shoji, Y. et al. (2008) A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir. Viruses, 2, 33–40.
107. Moore, P.L., Crooks, E.T., Porter, L., Zhu, P., Cayanan, C.S., Grise, H., Corcoran, P. et al. (2006) Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80, 2515–2528.
108. Mortimer, E., Maclean, J.M., Mbewana, S., Buys, A., Williamson, A.L., Hitzeroth, I.I. and Rybicki, E.P. (2012) Setting up a platform for plant-based influenza virus vaccine production in South Africa. BMC Biotechnol. 12, 14.
109. Moustafa, K., Makhzoum, A. and Tremouillaux-Guiller, J. (2016) Molecular farming on rescue of pharma industry for next generations. Crit. Rev. Biotechnol. 36, 840–850.
110. Nabel, G.J. (2013) Designing tomorrow's vaccines. N. Engl. J. Med. 368, 551–560.
111. Oliver, J.D., van der Wal, F.J., Bulleid, N.J. and High, S. (1997) Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science, 275, 86–88.
112. Oliver, J.D., Roderick, H.L., Llewellyn, D.H. and High, S. (1999) ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin. Mol. Biol. Cell. 10, 2573–2582.
113. Owens, R.J. and Compans, R.W. (1990) The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. Virology, 179, 827–833.
114. Paccalet, T., Bardor, M., Rihouey, C., Delmas, F., Chevalier, C., D'Aoust, M.A., Faye, L. et al. (2007) Engineering of a sialic acid synthesis pathway in transgenic plants by expression of bacterial Neu5Ac-synthesizing enzymes. Plant Biotechnol. J. 5, 16–25.
115. Pauthner, M., Havenar-Daughton, C., Sok, D., Nkolola, J.P., Bastidas, R., Boopathy, A.V., Carnathan, D.G. et al. (2017) Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity, 46, 1073–1088. e1076.
116. Pera, F.F., Mutepfa, D.L., Khan, A.M., Els, J.H., Mbewana, S., van Dijk, A.A., Rybicki, E.P. et al. (2015) Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana. Virol. J. 12, 205.
117. Phoolcharoen, W., Bhoo, S.H., Lai, H., Ma, J., Arntzen, C.J., Chen, Q. and Mason, H.S. (2011) Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnol. J. 9, 807–816.
118. Pillet, S., Racine, T., Nfon, C., Di Lenardo, T.Z., Babiuk, S., Ward, B.J., Kobinger, G.P. et al. (2015) Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets. Vaccine, 33, 6282–6289.
119. Pillet, S., Aubin, E., Trepanier, S., Bussiere, D., Dargis, M., Poulin, J.F., Yassine-Diab, B. et al. (2016) A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults. Clin. Immunol. 168, 72–87.
120. Pogrebnyak, N., Golovkin, M., Andrianov, V., Spitsin, S., Smirnov, Y., Egolf, R. and Koprowski, H. (2005) Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine. Proc. Natl Acad. Sci. U. S. A. 102, 9062–9067.
121. Pritchard, L.K., Vasiljevic, S., Ozorowski, G., Seabright, G.E., Cupo, A., Ringe, R., Kim, H.J. et al. (2015) Structural constraints determine the glycosylation of HIV-1 envelope trimers. Cell. Rep. 11, 1604–1613.
122. Quan, F.S., Lee, Y.T., Kim, K.H., Kim, M.C. and Kang, S.M. (2016) Progress in developing virus-like particle influenza vaccines. Expert. Rev. Vaccines, 15, 1281–1293.
123. Ringe, R.P., Sanders, R.W., Yasmeen, A., Kim, H.J., Lee, J.H., Cupo, A., Korzun, J. et al. (2013) Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc. Natl Acad. Sci. U. S. A. 110, 18256–18261.
124. Rosales-Mendoza, S., Salazar-Gonzalez, J.A., Decker, E.L. and Reski, R. (2016) Implications of plant glycans in the development of innovative vaccines. Expert. Rev. Vaccines, 15, 915–925.
125. Rosenberg, Y., Sack, M., Montefiori, D., Forthal, D., Mao, L., Hernandez-Abanto, S., Urban, L. et al. (2013) Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems. PLoS ONE, 8, e58724.
126. Rudolph, R. and Lilie, H. (1996) In vitro folding of inclusion body proteins. FASEB J. 10, 49–56.
127. Rutkevich, L.A., Cohen-Doyle, M.F., Brockmeier, U. and Williams, D.B. (2010) Functional relationship between protein disulfide isomerase family members during the oxidative folding of human secretory proteins. Mol. Biol. Cell. 21, 3093–3105.
128. Rybicki, E.P. (2009) Plant-produced vaccines: promise and reality. Drug Discov. Today 14, 16–24.
129. Rybicki, E.P. (2010) Plant-made vaccines for humans and animals. Plant Biotechnol. J. 8, 620–637.
130. Rybicki, E.P. (2014) Plant based vaccines against viruses. Virology Journal 11, 205.
131. Rybicki, E.P. (2017) Plant-made vaccines and reagents for the One Health initiative. Hum. Vaccin. Immunother. 13, 2912–2917.
132. Rybicki, E.P., Hitzeroth, I.I., Meyers, A., Dus Santos, M.J. and Wigdorovitz, A. (2013) Developing country applications of molecular farming: case studies in South Africa and Argentina. Curr. Pharm. Des. 19, 5612–5621.
133. Saejung, W., Fujiyama, K., Takasaki, T., Ito, M., Hori, K., Malasit, P., Watanabe, Y. et al. (2007) Production of dengue 2 envelope domain III in plant using TMV-based vector system. Vaccine, 25, 6646–6654.
134. Saibil, H. (2013) Chaperone machines for protein folding, unfolding and disaggregation. Nat. Rev. Mol. Cell. Biol. 14, 630–642.
135. Sanders, R.W. and Moore, J.P. (2017) Native-like Env trimers as a platform for HIV-1 vaccine design. Immunol. Rev. 275, 161–182.
136. Sanders, R.W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K.O., Kwong, P.D. et al. (2002) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76, 7293–7305.
137. Sanders, R.W., Derking, R., Cupo, A., Julien, J.P., Yasmeen, A., de Val, N., Kim, H.J. et al. (2013) A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9, e1003618.
138. Scanlan, C.N., Pantophlet, R., Wormald, M.R., Ollmann Saphire, E., Stanfield, R., Wilson, I.A., Katinger, H. et al. (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1–>2 mannose residues on the outer face of gp120. J. Virol. 76, 7306–7321.
139. Seveno, M., Bardor, M., Paccalet, T., Gomord, V., Lerouge, P. and Faye, L. (2004) Glycoprotein sialylation in plants? Nat. Biotechnol. 22, 1351–1352; author reply 1352–1353.
140. Shao, Y. and Williamson, C. (2012) The HIV-1 epidemic: low- to middle-income countries. Cold Spring Harb. Perspect Med. 2, a007187.
141. Sharma, S.K., de Val, N., Bale, S., Guenaga, J., Tran, K., Feng, Y., Dubrovskaya, V. et al. (2015) Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design. Cell. Rep. 11, 539–550.
142. Shoji, Y., Chichester, J.A., Bi, H., Musiychuk, K., de la Rosa, P., Goldschmidt, L., Horsey, A. et al. (2008) Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine, 26, 2930–2934.
143. Shoji, Y., Bi, H., Musiychuk, K., Rhee, A., Horsey, A., Roy, G., Green, B. et al. (2009a) Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine, 27, 1087–1092.
144. Shoji, Y., Farrance, C.E., Bi, H., Shamloul, M., Green, B., Manceva, S., Rhee, A. et al. (2009b) Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine, 27, 3467–3470.
145. Shoji, Y., Chichester, J.A., Jones, M., Manceva, S.D., Damon, E., Mett, V., Musiychuk, K. et al. (2011) Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum. Vaccin. 7(Suppl), 41–50.
146. Shoji, Y., Farrance, C.E., Bautista, J., Bi, H., Musiychuk, K., Horsey, A., Park, H. et al. (2012) A plant-based system for rapid production of influenza vaccine antigens. Influenza Other Respir. Viruses, 6, 204–210.
147. Sijmons, P.C., Dekker, B.M., Schrammeijer, B., Verwoerd, T.C., van den Elzen, P.J. and Hoekema, A. (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology (N Y) 8, 217–221.
148. Skehel, J.J., Stevens, D.J., Daniels, R.S., Douglas, A.R., Knossow, M., Wilson, I.A. and Wiley, D.C. (1984) A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl Acad. Sci. U. S. A. 81, 1779–1783.
149. Sok, D., Doores, K.J., Briney, B., Le, K.M., Saye-Francisco, K.L., Ramos, A., Kulp, D.W. et al. (2014) Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. Sci. Transl. Med. 6, 236ra263.
150. Sok, D., Pauthner, M., Briney, B., Lee, J.H., Saye-Francisco, K.L., Hsueh, J., Ramos, A. et al. (2016) A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans. Immunity, 45, 31–45.
151. Sommer, T. and Jentsch, S. (1993) A protein translocation defect linked to ubiquitin conjugation at the endoplasmic reticulum. Nature, 365, 176–179.
152. Steinhauer, D.A. (1999) Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology, 258, 1–20.
153. Steinkellner, H. and Castilho, A. (2015) N-glyco-engineering in plants: update on strategies and major achievements. Methods Mol. Biol. 1321, 195–212.
154. Stieneke-Grober, A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C., Klenk, H.D. et al. (1992) Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11, 2407–2414.
155. Stoger, E., Fischer, R., Moloney, M. and Ma, J.K. (2014) Plant molecular pharming for the treatment of chronic and infectious diseases. Annu. Rev. Plant Biol. 65, 743–768.
156. Strasser, R. (2018) Protein Quality Control in the Endoplasmic Reticulum of Plants. Annu. Rev. Plant Biol. 69, 147–172.
157. Strasser, R., Stadlmann, J., Schahs, M., Stiegler, G., Quendler, H., Mach, L., Glossl, J. et al. (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6, 392–402.
158. Strasser, R., Altmann, F. and Steinkellner, H. (2014) Controlled glycosylation of plant-produced recombinant proteins. Curr. Opin. Biotechnol. 30, 95–100.
159. Streatfield, S.J., Kushnir, N. and Yusibov, V. (2015) Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents. Plant Biotechnol. J. 13, 1136–1159.
160. Tessier, D.C., Thomas, D.Y., Khouri, H.E., Laliberte, F. and Vernet, T. (1991) Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene, 98, 177–183.
161. Tottey, S., Shoji, Y., Jones, R.M., Chichester, J.A., Green, B.J., Musiychuk, K., Si, H. et al. (2018) Plant-produced subunit vaccine candidates against yellow fever induce virus neutralizing antibodies and confer protection against viral challenge in animal models. Am. J. Trop. Med. Hyg. 98, 420–431.
162. Tran, K., Poulsen, C., Guenaga, J., de Val, N., Wilson, R., Sundling, C., Li, Y. et al. (2014) Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign. Proc. Natl Acad. Sci. U. S. A. 111, E738–E747.
163. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K. et al. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100–1108.
164. Tschofen, M., Knopp, D., Hood, E. and Stoger, E. (2016) Plant Molecular Farming: Much More than Medicines. Annu. Rev. Anal. Chem. (Palo Alto Calif) 9, 271–294.
165. Vollenweider, F., Benjannet, S., Decroly, E., Savaria, D., Lazure, C., Thomas, G., Chretien, M. et al. (1996) Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. Biochem. J. 314(Pt 2), 521–532.
166. Wada, I., Rindress, D., Cameron, P.H., Ou, W.J., Doherty, J.J. 2nd, Louvard, D., Bell, A.W. et al. (1991) SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem. 266, 19599–19610.
167. Ward, C.L., Omura, S. and Kopito, R.R. (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell, 83, 121–127.
168. Ward, B.J., Landry, N., Trepanier, S., Mercier, G., Dargis, M., Couture, M., D'Aoust, M.A. et al. (2014) Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines. Vaccine, 32, 6098–6106.
169. Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F. et al. (2003) Antibody neutralization and escape by HIV-1. Nature, 422, 307–312.
170. Wei, C.J., Boyington, J.C., Dai, K., Houser, K.V., Pearce, M.B., Kong, W.P., Yang, Z.Y. et al. (2010) Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2, 24ra21.
171. WHO. (2014) Influenza vaccine viruses and reagents. Geneva: World Health Organisation.
172. Wilbers, R.H., Westerhof, L.B., van Raaij, D.R., van Adrichem, M., Prakasa, A.D., Lozano-Torres, J.L., Bakker, J. et al. (2016) Co-expression of the protease furin in Nicotiana benthamiana leads to efficient processing of latent transforming growth factor-beta1 into a biologically active protein. Plant Biotechnol. J. 14, 1695–1704.
173. Yakob, L. and Walker, T. (2016) Zika virus outbreak in the Americas: the need for novel mosquito control methods. Lancet Glob. Health, 4, e148–e149.
174. Yang, M., Lai, H., Sun, H. and Chen, Q. (2017a) Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci. Rep. 7, 7679.
175. Yang, M., Sun, H., Lai, H., Hurtado, J. and Chen, Q. (2017b) Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice. Plant Biotechnol. J. 16, 572–580.
176. Yap, Y.K. and Smith, D.R. (2010) Strategies for the plant-based expression of dengue subunit vaccines. Biotechnol. Appl. Biochem. 57, 47–53.
177. Zabel, F., Kundig, T.M. and Bachmann, M.F. (2013) Virus-induced humoral immunity: on how B cell responses are initiated. Curr. Opin. Virol. 3, 357–362.
178. Zapun, A., Darby, N.J., Tessier, D.C., Michalak, M., Bergeron, J.J. and Thomas, D.Y. (1998) Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J. Biol. Chem. 273, 6009–6012.
179. Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J. et al. (2016) Structural Basis of Zika Virus-Specific Antibody Protection. Cell, 166, 1016–1027.
180. Zhou, J.Y., Cheng, L.Q., Zheng, X.J., Wu, J.X., Shang, S.B., Wang, J.Y. and Chen, J.G. (2004) Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus. J. Biotechnol. 111, 121–130.
181. Zumla, A., Dar, O., Kock, R., Muturi, M., Ntoumi, F., Kaleebu, P., Eusebio, M. et al. (2016) Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int. J. Infect. Dis. 47, 5–9.